BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36845744)

  • 1. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of prognostic indicator based on NAD+ metabolism related genes in glioma.
    Chen X; Wu W; Wang Y; Zhang B; Zhou H; Xiang J; Li X; Yu H; Bai X; Xie W; Lian M; Wang M; Wang J
    Front Surg; 2023; 10():1071259. PubMed ID: 36778644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of nicotinamide adenine dinucleotide (NAD
    Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
    J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
    Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
    Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer.
    Hu D; Du J; Cheng Y; Xing Y; He R; Liang X; Li H; Yang Y
    Biomol Biomed; 2024 Mar; 24(2):346-359. PubMed ID: 37688492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of NAD+ metabolism-related biomarkers in patients with diabetic peripheral neuropathy.
    Ye C; Fu Y; Zhou X; Zhou F; Zhu X; Chen Y
    Front Endocrinol (Lausanne); 2024; 15():1309917. PubMed ID: 38464965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of NAD
    Lin L; Chen L; Xie Z; Chen J; Li L; Lin A
    Front Genet; 2022; 13():905238. PubMed ID: 35783253
    [No Abstract]   [Full Text] [Related]  

  • 9. A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma.
    Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X
    J Inflamm Res; 2022; 15():17-32. PubMed ID: 35018108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma.
    Peng Z; Wu Y; Wang J; Gu S; Wang Y; Xue B; Fu P; Xiang W
    Stem Cell Res Ther; 2023 Apr; 14(1):56. PubMed ID: 37005685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of an NAD + metabolism-related lncRNA signature for predicting the prognosis and immune landscape of acute myeloid leukemia.
    Zhu Y; Jian J; Niu Y; Yang X; Guo Y; Zhao L; Liu B
    Hematology; 2023 Dec; 28(1):2231760. PubMed ID: 37417449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The study of an anoikis-related signature to predict glioma prognosis and immune infiltration.
    Zhang D; Wang Y; Zhou H; Han X; Hou L; Lv Z; Xue X
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12659-12676. PubMed ID: 37450027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
    Xiang Z; Chen X; Lv Q; Peng X
    Front Genet; 2021; 12():697819. PubMed ID: 34408772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
    Chen Z; Wu T; Yan Z; Zhang M
    Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD+ associated genes as potential biomarkers for predicting the prognosis of gastric cancer.
    Sun X; Wen H; Li F; Bukhari I; Ren F; Xue X; Zheng P; Mi Y
    Oncol Res; 2023; 32(2):283-296. PubMed ID: 38186577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.